Lv11
48 积分 2026-01-04 加入
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir
5小时前
待确认
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
1个月前
已完结
Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71
2个月前
已完结
皖公网安备34019202002308
